The BiTE (bispecific T‐cell engager) platform: Development and future potential of a targeted immuno‐oncology therapy across tumor types von Einsele, Hermann, Borghaei, Hossein, Orlowski, Robert Z., Subklewe, Marion, Roboz, Gail J., Zugmaier, Gerhard, Kufer, Peter, Iskander, Karim, Kantarjian, Hagop M.

Volltext

Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes von Sallman, David A., DeZern, Amy E., Garcia-Manero, Guillermo, Steensma, David P., Roboz, Gail J., Sekeres, Mikkael A., Cluzeau, Thomas, Sweet, Kendra L., McLemore, Amy, McGraw, Kathy L., Puskas, John, Zhang, Ling, Yao, Jiqiang, Mo, Qianxing, Nardelli, Lisa, Al Ali, Najla H., Padron, Eric, Korbel, Greg, Attar, Eyal C., Kantarjian, Hagop M., Lancet, Jeffrey E., Fenaux, Pierre, List, Alan F., Komrokji, Rami S.

Volltext

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party von Schuurhuis, Gerrit J., Heuser, Michael, Freeman, Sylvie, Béné, Marie-Christine, Buccisano, Francesco, Cloos, Jacqueline, Grimwade, David, Haferlach, Torsten, Hills, Robert K., Hourigan, Christopher S., Jorgensen, Jeffrey L., Kern, Wolfgang, Lacombe, Francis, Maurillo, Luca, Preudhomme, Claude, van der Reijden, Bert A., Thiede, Christian, Venditti, Adriano, Vyas, Paresh, Wood, Brent L., Walter, Roland B., Döhner, Konstanze, Roboz, Gail J., Ossenkoppele, Gert J.

Volltext

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia von Stein, Eytan M., DiNardo, Courtney D., Pollyea, Daniel A., Fathi, Amir T., Roboz, Gail J., Altman, Jessica K., Stone, Richard M., DeAngelo, Daniel J., Levine, Ross L., Flinn, Ian W., Kantarjian, Hagop M., Collins, Robert, Patel, Manish R., Frankel, Arthur E., Stein, Anthony, Sekeres, Mikkael A., Swords, Ronan T., Medeiros, Bruno C., Willekens, Christophe, Vyas, Paresh, Tosolini, Alessandra, Xu, Qiang, Knight, Robert D., Yen, Katharine E., Agresta, Sam, de Botton, Stephane, Tallman, Martin S.

Volltext

Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study von Garcia-Manero, Guillermo, Griffiths, Elizabeth A., Steensma, David P., Roboz, Gail J., Wells, Richard, McCloskey, James, Odenike, Olatoyosi, DeZern, Amy E., Yee, Karen, Busque, Lambert, O'Connell, Casey, Michaelis, Laura C., Brandwein, Joseph, Kantarjian, Hagop, Oganesian, Aram, Azab, Mohammad, Savona, Michael R.

Volltext

Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia von Leonard, John P, Martin, Peter, Roboz, Gail J

Volltext

Novel approaches to the treatment of acute myeloid leukemia von Roboz, Gail J

Volltext

Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia von Sugita, Mayumi, Galetto, Roman, Zong, Hongliang, Ewing-Crystal, Nathan, Trujillo-Alonso, Vicenta, Mencia-Trinchant, Nuria, Yip, Winnie, Filipe, Stephanie, Lebuhotel, Celine, Gouble, Agnès, Hassane, Duane C., Smith, Julianne, Roboz, Gail J., Guzman, Monica L.

Volltext

First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leuk... von FELDMAN, Eric J, LANCET, Jeffrey E, LOUIE, Arthur C, KOLITZ, Jonathan E, RITCHIE, Ellen K, ROBOZ, Gail J, LIST, Alan F, ALLEN, Steven L, ASATIANI, Ekatherine, MAYER, Lawrence D, SWENSON, Christine

Volltext

Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 tria... von Garcia-Manero, Guillermo, Dr Prof, Fenaux, Pierre, Prof, Al-Kali, Aref, MD, Baer, Maria R, Prof, Sekeres, Mikkael A, Prof, Roboz, Gail J, Prof, Gaidano, Gianluca, Prof, Scott, Bart L, MD, Greenberg, Peter, Prof, Platzbecker, Uwe, Prof, Steensma, David P, MD, Kambhampati, Suman, MD, Kreuzer, Karl-Anton, Prof, Godley, Lucy A, Prof, Atallah, Ehab, MD, Collins, Robert, Prof, Kantarjian, Hagop, Prof, Jabbour, Elias, MD, Wilhelm, Francois E, MD, Azarnia, Nozar, PhD, Silverman, Lewis R, MD

Volltext

Oral arsenic trioxide ORH-2014 pharmacokinetic and safety profile in patients with advanced hematologic disorders von Ravandi, Farhad, Koumenis, Iphigenia, Johri, Anandhi, Tallman, Martin, Roboz, Gail J., Strickland, Stephen, Garcia-Manero, Guillermo, Borthakur, Gautam, Naqvi, Kiran, Meyer, Meghan, Pudipeddi, Madhu, Nidarmarthy, Sirish, Vaddi, Kris, Kantarjian, Hagop

Volltext

Paradigms for Precision Medicine in Epichaperome Cancer Therapy von Pillarsetty, Nagavarakishore, Jhaveri, Komal, Taldone, Tony, Caldas-Lopes, Eloisi, Punzalan, Blesida, Joshi, Suhasini, Bolaender, Alexander, Uddin, Mohammad M., Rodina, Anna, Yan, Pengrong, Ku, Anson, Ku, Thomas, Shah, Smit K., Lyashchenko, Serge, Burnazi, Eva, Wang, Tai, Lecomte, Nicolas, Janjigian, Yelena, Younes, Anas, Batlevi, Connie W., Guzman, Monica L., Roboz, Gail J., Koziorowski, Jacek, Zanzonico, Pat, Alpaugh, Mary L., Corben, Adriana, Modi, Shanu, Norton, Larry, Larson, Steven M., Lewis, Jason S., Chiosis, Gabriela, Gerecitano, John F., Dunphy, Mark P.S.

Volltext

Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial von Kreitman, Robert J., Dearden, Claire, Zinzani, Pier Luigi, Delgado, Julio, Robak, Tadeusz, le Coutre, Philipp D., Gjertsen, Bjorn T., Troussard, Xavier, Roboz, Gail J., Karlin, Lionel, Gladstone, Douglas E., Kuptsova-Clarkson, Nataliya, Liu, Shiyao, Patel, Priti, Rotolo, Federico, Mitry, Emmanuel, Pastan, Ira, Giles, Francis

Volltext

A Hyperactive Signalosome in Acute Myeloid Leukemia Drives Addiction to a Tumor-Specific Hsp90 Species von Zong, Hongliang, Gozman, Alexander, Caldas-Lopes, Eloisi, Taldone, Tony, Sturgill, Eric, Brennan, Sarah, Ochiana, Stefan O., Gomes-DaGama, Erica M., Sen, Siddhartha, Rodina, Anna, Koren, John, Becker, Michael W., Rudin, Charles M., Melnick, Ari, Levine, Ross L., Roboz, Gail J., Nimer, Stephen D., Chiosis, Gabriela, Guzman, Monica L.

Volltext

Current treatment of acute myeloid leukemia von Roboz, Gail J

Volltext

A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia von Pratz, Keith W, Kaplan, Jason, Levy, Moshe, Bixby, Dale, Burke, Patrick W, Erba, Harry, Wise-Draper, Trisha M, Roboz, Gail J, Papadantonakis, Nikolaos, Rajkhowa, Trivikram, Hernandez, Daniela, Dobler, Iwona, Gregory, Richard C, Li, Cheryl, Wang, Shining, Stumpo, Kate, Kannan, Karuppiah, Miao, Harry, Levis, Mark

Volltext

Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QU... von Wei, Andrew H, Roboz, Gail J, Dombret, Herve, Dohner, Hartmut, Schuh, Andre C, Montesinos, Pau, Selleslag, Dominik, Bondarenko, Sergey N, Prebet, Thomas, Lai, Yinzhi, Skikne, Barry, Beach, C L, Ravandi, Farhad

Volltext

Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia von Roboz, Gail J, Ritchie, Ellen K, Dault, Yulia, Lam, Linda, Marshall, Danielle C, Cruz, Nicole M, Hsu, Hsiao-Ting C, Hassane, Duane C, Christos, Paul J, Ippoliti, Cindy, Scandura, Joseph M, Guzman, Monica L

Volltext

Single‐cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3‐ITD‐mutated AML stem/progenitor cells von Han, Lina, Qiu, Peng, Zeng, Zhihong, Jorgensen, Jeffrey L., Mak, Duncan H., Burks, Jared K., Schober, Wendy, McQueen, Teresa J., Cortes, Jorge, Tanner, Scott D., Roboz, Gail J., Kantarjian, Hagop M., Kornblau, Steven M., Guzman, Monica L., Andreeff, Michael, Konopleva, Marina

Volltext

Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis von TEFFERI, Ayalew, VERSTOVSEK, Srdan, THIELE, Juergen, KVASNICKA, Hans M, VARDIMAN, James W, YANMING ZHANG, NEBIYOU BEKELE, B, MESA, Ruben A, GALE, Robert P, KANTARJIAN, Hagop M, BAROSI, Giovanni, PASSAMONTI, Francesco, ROBOZ, Gail J, GISSLINGER, Heinz, PAQUETTE, Ronald L, CERVANTES, Francisco, RIVERA, Candido E, JOACHIM DEEG, H

Volltext